HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H Walczak Selected Research
H Walczak Research Topics
Disease
15
Neoplasms (Cancer)
12/2019 - 06/2000
7
Necrosis
11/2014 - 04/2000
3
Melanoma (Melanoma, Malignant)
07/2013 - 05/2008
2
Head and Neck Neoplasms (Head and Neck Cancer)
11/2014 - 10/2014
2
Squamous Cell Carcinoma of Head and Neck
11/2014 - 10/2014
2
Inflammation (Inflammations)
11/2014 - 11/2013
2
Hepatocellular Carcinoma (Hepatoma)
11/2014 - 07/2004
2
Infections
06/2013 - 12/2001
2
Glioma (Gliomas)
02/2008 - 07/2001
1
Hepatitis
11/2014
1
Chronic Hepatitis (Chronic Active Hepatitis)
11/2014
1
Liver Diseases (Liver Disease)
11/2014
1
Liver Failure
11/2014
1
Lung Neoplasms (Lung Cancer)
03/2014
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014
1
Reperfusion Injury
11/2013
1
Human Influenza (Influenza)
06/2013
1
Carcinoma (Carcinomatosis)
04/2008
1
Glioblastoma (Glioblastoma Multiforme)
02/2008
1
Lymphoma (Lymphomas)
03/2002
1
Adenocarcinoma
07/2001
1
Renal Cell Carcinoma (Grawitz Tumor)
11/2000
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2000
1
Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000
Drug/Important Bio-Agent (IBA)
10
Ligands
IBA
11/2014 - 06/2000
7
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2014 - 06/2000
6
Caspase 8 (Caspase-8)
IBA
11/2014 - 01/2000
5
Death Domain Receptors
IBA
05/2016 - 01/2000
5
Proteins (Proteins, Gene)
FDA Link
11/2014 - 02/2008
5
TNF-Related Apoptosis-Inducing Ligand
IBA
09/2014 - 04/2000
4
Fas Ligand Protein (Fas Ligand)
IBA
05/2008 - 07/2001
3
Pharmaceutical Preparations
IBA
07/2013 - 06/2000
3
NF-kappa B (NF-kB)
IBA
11/2008 - 04/2000
2
Interleukin-4 (Interleukin 4)
IBA
12/2019 - 04/2008
2
Antineoplastic Agents (Antineoplastics)
IBA
11/2014 - 10/2014
2
Phosphotransferases (Kinase)
IBA
11/2014 - 02/2008
2
Caspases
IBA
10/2014 - 06/2010
2
Bortezomib (Velcade)
FDA Link
10/2014 - 06/2010
1
Caspase 10
IBA
11/2014
1
BH3 Interacting Domain Death Agonist Protein
IBA
11/2014
1
Type I Tumor Necrosis Factor Receptors
IBA
11/2014
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2014
1
Cyclin-Dependent Kinase 9
IBA
03/2014
1
N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamide
IBA
03/2014
1
Cisplatin (Platino)
FDA Link
Generic
07/2013
1
Poly I-C
IBA
06/2013
1
Toll-Like Receptor 3
IBA
06/2013
1
Small Interfering RNA (siRNA)
IBA
02/2008
1
Glucose (Dextrose)
FDA Link
Generic
02/2008
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
02/2008
1
DNA (Deoxyribonucleic Acid)
IBA
01/2008
1
Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)
IBA
02/2007
1
factor A
IBA
02/2007
1
butyl phosphorotrithioate (DEF)
IBA
02/2007
1
Superantigens
IBA
03/2002
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
03/2002
1
Antigens
IBA
03/2002
1
Antiviral Agents (Antivirals)
IBA
12/2001
1
Protein Kinase C
IBA
07/2001
1
Lomustine (CCNU)
FDA Link
07/2001
1
Cytochromes c (Cytochrome c)
IBA
07/2001
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
07/2001
1
Topotecan (Hycamtin)
FDA Link
Generic
11/2000
1
Etoposide (VP 16)
FDA Link
Generic
06/2000
1
Cytokines
IBA
04/2000
1
CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)
IBA
02/2000
Therapy/Procedure
8
Therapeutics
05/2016 - 04/2001
4
Drug Therapy (Chemotherapy)
10/2014 - 06/2000
1
Transplantation
11/2013
1
Chemoradiotherapy
07/2001
1
Aftercare (After-Treatment)
02/2000